Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Cancer of Liver

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balliet, RM; Chen, G; Dellinger, RW; Lazarus, P1

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Cancer of Liver

ArticleYear
UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:3

    Topics: Caco-2 Cells; Carcinogens; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Gene Frequency; Genes, Reporter; Genetic Association Studies; Genetic Predisposition to Disease; Genomic Structural Variation; Glucuronosyltransferase; Humans; Isoenzymes; Liver Neoplasms; Metabolic Detoxication, Phase II; Minor Histocompatibility Antigens; Nitrosamines; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Sequence Deletion

2010